Literature DB >> 10962597

Spastic movement disorder.

V Dietz1.   

Abstract

This review deals with the neuronal mechanisms underlying spastic movement disorder, assessed by electrophysiological means with the aim of first, a better understanding of the underlying pathophysiology and second, the selection of an adequate treatment. For the patient usually one of the first symptoms of a lesion within the central motor system represents the movement disorder, which is most characteristic during locomotion in patients with spasticity. The clinical examination reveals exaggerated tendon tap reflexes and increased muscle tone typical of the spastic movement disorder. However, today we know that there exists only a weak relationship between the physical signs obtained during the clinical examination in a passive motor condition and the impaired neuronal mechanisms being in operation during an active movement. By the recording and analysis of electrophysiological and biomechanical parameters during a functional movement such as locomotion, the significance of, for example, impaired reflex behaviour or pathophysiology of muscle tone and its contribution to the movement disorder can reliably be assessed. Consequently, an adequate treatment should not be restricted to the cosmetic therapy and correction of an isolated clinical parameter but should be based on the pathophysiology and significance of the mechanisms underlying the disorder of functional movement which impairs the patient.

Entities:  

Mesh:

Year:  2000        PMID: 10962597     DOI: 10.1038/sj.sc.3101030

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  12 in total

1.  Simultaneous characterizations of reflex and nonreflex dynamic and static changes in spastic hemiparesis.

Authors:  Li-Qun Zhang; Sun G Chung; Yupeng Ren; Lin Liu; Elliot J Roth; W Zev Rymer
Journal:  J Neurophysiol       Date:  2013-05-01       Impact factor: 2.714

Review 2.  Neurobiology of rehabilitation.

Authors:  Bruce H Dobkin
Journal:  Ann N Y Acad Sci       Date:  2004-12       Impact factor: 5.691

3.  TFG associated hereditary spastic paraplegia: an addition to the phenotypic spectrum.

Authors:  Huma Tariq; Sadaf Naz
Journal:  Neurogenetics       Date:  2017-01-25       Impact factor: 2.660

4.  Cutaneous inputs from the back abolish locomotor-like activity and reduce spastic-like activity in the adult cat following complete spinal cord injury.

Authors:  Alain Frigon; Yann Thibaudier; Michael D Johnson; C J Heckman; Marie-France Hurteau
Journal:  Exp Neurol       Date:  2012-04-01       Impact factor: 5.330

5.  Vibration attenuates spasm-like activity in humans with spinal cord injury.

Authors:  Bradley A DeForest; Jorge Bohorquez; Monica A Perez
Journal:  J Physiol       Date:  2020-06-10       Impact factor: 5.182

6.  Treatment patterns of in-patient spasticity medication use after traumatic spinal cord injury: a prospective cohort study.

Authors:  Kaila A Holtz; Elena Szefer; Vanessa K Noonan; Brian K Kwon; Patricia B Mills
Journal:  Spinal Cord       Date:  2018-06-14       Impact factor: 2.772

7.  The occurrence of the Babinski sign in complete spinal cord injury.

Authors:  Jens A Petersen; Martin Schubert; Volker Dietz
Journal:  J Neurol       Date:  2009-08-25       Impact factor: 4.849

8.  A longitudinal study of self-reported spasticity among individuals with chronic spinal cord injury.

Authors:  Nicole D DiPiro; Chao Li; James S Krause
Journal:  Spinal Cord       Date:  2017-12-22       Impact factor: 2.772

Review 9.  Recent advances in 3D bioprinting of musculoskeletal tissues.

Authors:  Tyler Potyondy; Jorge Alfredo Uquillas; Peyton J Tebon; Batzaya Byambaa; Anwarul Hasan; Maryam Tavafoghi; Heloise Mary; George E Aninwene; Ippokratis Pountos; Ali Khademhosseini; Nureddin Ashammakhi
Journal:  Biofabrication       Date:  2021-03-10       Impact factor: 9.954

10.  Bilateral and asymmetrical contributions of passive and active ankle plantar flexors stiffness to spasticity in humans with spinal cord injury.

Authors:  Bing Chen; Sina Sangari; Jakob Lorentzen; Jens B Nielsen; Monica A Perez
Journal:  J Neurophysiol       Date:  2020-05-20       Impact factor: 2.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.